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Introduction: The aim of the study was to assess whether adults admitted to hospitals with both Intensive Care
Units (ICU) and Intermediate Care Units (IMCU) have lower in-hospital mortality than those admitted to ICUs
without an IMCU.
Methods: An observational multinational cohort study performed on patients admitted to participating ICUs during
a four-week period. IMCU was defined as any physically and administratively independent unit open 24 hours a
day, seven days a week providing a level of care lower than an ICU but higher than a ward. Characteristics of
hospitals, ICUs and patients admitted to study ICUs were recorded. The main outcome was all-cause in-hospital
mortality until hospital discharge (censored at 90 days).
Results: One hundred and sixty-seven ICUs from 17 European countries enrolled 5,834 patients. Overall, 1,113
(19.1%) patients died in the ICU and 1,397 died in hospital, with a total of 1,397 (23.9%) deaths. The illness severity
was higher for patients in ICUs with an IMCU (median Simplified Acute Physiology Score (SAPS) II: 37) than for
patients in ICUs without an IMCU (median SAPS II: 29, P <0.001). After adjustment for patient characteristics at
admission such as illness severity, and ICU and hospital characteristics, the odds ratio of mortality was 0.63 (95% CI
0.45 to 0.88, P = 0.007) in favour of the presence of IMCU. The protective effect of the IMCU was absent in patients
who were admitted for basic observation, for example, after surgery (odds ratio 1.15, 95% CI 0.65 to 2.03, P = 0.630)
but was strong in patients admitted to an ICU for other reasons (odds ratio 0.54, 95% CI 0.37 to 0.80, P = 0.002).
Conclusions: The presence of an IMCU in the hospital is associated with significantly reduced adjusted hospital
mortality for adults admitted to the ICU. This effect is relevant for the patients requiring full intensive treatment.
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The Intensive Care Unit (ICU) is the part of the hospital
where care is provided to the sickest patients. It is typi-
fied by having a high level of monitoring and therapeutic
technologies, a very high degree of organization and
high staff to patient ratios. Despite the high severity of
illness of patents admitted to ICU, most improve to the
point to be discharged to a normal ward care environ-
ment. A significant proportion of these ICU-discharged
patients subsequently die in the hospital with post-ICU
mortality rates ranging from 6 to 27% [1-7] either as a
result of residual organ dysfunction/failure or due to the
inability of the staff in lower levels of care to cope ap-
propriately with the needs of these patients [8].
Premature discharge from ICU is more likely to occur
at night due to the pressure for beds on ICU, and is as-
sociated with higher risk of death [9]. Suggested factors
that might account for a worse outcome of prematurely
discharged patients are inferior quantities and qualities
of care available both during the transfer and at the des-
tination. To facilitate earlier ICU discharge for patients
needing more care than could be provided on wards,
Intermediate Care Units (IMCUs), with a level of nursing
staff (and costs) lower than ICU although higher than the
general wards, have been proposed [10-13]. Other positive
effects of the presence of an IMCU include a reduction in
the number of unplanned readmissions to ICU as a conse-
quence of providing more monitoring and nursing care
than is available on hospital wards [14-16] and a decrease
in hospital mortality rates due to a lower pressure on the
availability of beds in ICUs [17]. Moreover, an IMCU may
also act as a step-up unit for patients deteriorating on
wards ensuring timely care, and specialized IMCUs like
coronary, respiratory or stroke units can treat patients
never needing intensive care admission. This later effect is
highly debated, since it can delay the immediate admission
of a patient with impending critical illness to the ICU, just
wasting time for the patient to receive the appropriate
level of care.
The efficacy of IMCUs in Europe has been questioned
[18] and the pertinent literature shows variable results.
In a study performed on the EURICUS-I database [19]
the sensitivity analysis on in-hospital mortality showed
that patients discharged to IMCUs had a better outcome
than patients discharged to the ward. Beck et al. [20]
found a higher risk of post-ICU mortality for late
(20.00 h to 07.59 h) discharges to hospital wards in com-
parison with late discharges to IMCU. More recently, an
evaluation of the modernisation of adult critical care ser-
vices in England showed that the increase in the number
of staffed ICU beds started by the Department of Health
in 2000 involved more high dependency than intensive
care beds (increased by 106% and 23%, respectively), and
was associated with reductions in the adjusted mortality,and both transfers between units and unplanned night
discharges [21]. On the other hand, a study comparing
patients admitted to IMCU with low-risk ICU patients
[22] reported that the former had significantly higher
hospital mortality than the latter, despite a lower severity
of illness; however, there were differences in the IMCU
and ICU case mix. More recently, Peelen et al. [23] who
studied severe sepsis patients admitted to Dutch ICUs
found that the presence of an IMCU as a step-down
facility was associated with greater in-hospital mortality.
Among the possible explanations, the authors mention
hospital case-mix differences, unrevealed confounders
but also the possibility of premature discharge when an
IMCU is available. Moreover, Solberg et al. did not find
a decrease in ICU readmissions after introducing an
IMCU [24] while Keegan et al. found an increase of ICU
readmission after the introduction of a non-intensivist-
directed speciality-specific progressive care unit [25].
Overall, the potential effect of an IMCU can be assigned
to a higher nurse to patient ratio than the one existing
in regular wards [26] and/or its ability to cope with
residual patient organ dysfunction/failures [8].
The primary aim of this observational multinational
European cohort study was to assess whether the patients
admitted to ICUs with an IMCU in the hospital have
lower hospital mortality than those admitted to ICUs
without an IMCU in the same hospital.
Material and methods
The European Mortality and Length Of ICU Stay
(ELOISE) study was designed and endorsed by the
Working Group on Health Economics of the European
Society of Intensive Care Medicine (ESICM). The country
coordinators (listed in the Appendix) directly approached
colleagues to invite them to participate and helped
them obtain any regulatory authority approvals as appro-
priate. Local study coordinators (listed in the Appendix)
were responsible for obtaining any applicable permissions
from local ethics bodies, answering the study unit
questionnaire, training their colleagues and supervis-
ing the daily collection of patient data, getting hos-
pital discharge data, transmitting patient data without
any personally identifiable information to the Co-
ordination and Communications Centre (CCC), and
performing data re-abstraction of selected cases for
quality control. During the study period, the CCC
was active for management of the website [27], as-
signment of code to each study unit, dissemination of
information, help in solving problems concerning def-
initions and software, and periodic email transmission
of reminders.
The ethics requirements in different countries and the
list of the ethics bodies that approved the study are
reported in the acknowledgements section.
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This questionnaire was discussed in the Working Group
of ESICM and finalized by the members of the Steering
Committee (listed in the Appendix). It was designed to
collect information about the unit and the hospital
where the unit was located. However, we did not formally
validate our study unit questionnaire. Each local coordin-
ator answered the questionnaire and reported the highest
Level of Care (LOC) provided by the participating
unit to the patients. The LOC was defined according
to the recently published ESICM recommendations
on basic requirements for ICUs [28] where LOC III repre-
sents patients with multiple acute vital organ failure, LOC
II represents patients requiring monitoring and pharma-
cological and/or device-related support of only one acutely
failing vital organ system, and LOC I patients experience
signs of organ dysfunction necessitating continuous mo-
nitoring and minor pharmacological or device-related
support. For the present study an IMCU was defined as
any physically and administratively independent unit pro-
viding LOC I/II to patients open twenty-four hours per
day, seven days per week.
Local coordinators collected data on the hospital char-
acteristics (number of acute care beds and annual number
of hospital admissions), and numbers of LOC III, II and I
units present in the hospital. They provided information
about the organization of the study unit including the
number of active beds and actual staffing. Some ICUs re-
ported having intermediate care beds physically included
in the unit. Therefore, to analyse nurse to patient ratios of
these ICUs the number of ICU beds was adjusted consid-
ering that two intermediate care beds inside the ICU equal
one ICU bed [28]. The local coordinators were also asked
as to whether there was any possibility of allocating extra
beds inside the unit when necessary.
Data collection
An Excel file with plausibility limits was provided to
participating units by the CCC through the website,
where the study protocol, Case Report Form and de-
tailed definitions of the variables were available. All
patients aged ≥16 years, consecutively admitted to a
participating unit during the study period, not admitted
only for organ donation, and without any limitations of
care at ICU admission were included. Informed consent
was waived for the ICUs of some countries (Austria,
Czech Republic, Denmark, Germany, France, Norway,
Poland), while in other countries it was required by some
ethics bodies but not by others. Accordingly, the local
study coordinators obtained the patient consent to partici-
pate in the study where appropriate. Participating units
chose one of two available study periods (either from
7 November to 4 December 2011, or from 16 January
to 12 February 2012) for patient data collection. Themaximum number of admissions collected by each
unit was limited to 100.
The patient data collected for the study included vari-
ables to compute Simplified Acute Physiology Score
(SAPS) II [29] and SAPS 3 at admission [6,30], and
Sequential Organ Failure Assessment (SOFA) [31] and
nursing workload index (NEMS) [32] on the last day in
the study unit for survivors. A follow-up until hospital
discharge was performed and censored at 90 days after
admission to the study unit, and date, time, vital status
at hospital discharge as well as any transfer to a LOC
higher than ward after discharge from the study unit
and before hospital discharge were recorded. When a
patient was discharged from the study unit to another
acute hospital, date, time and vital status at hospital dis-
charge were assumed to be the same as unit discharge.
For the calculation of each severity score, if the number
of missing values for a single admission was ≤3 the miss-
ing values were scored as normal. When more than
three values were missing, the entire score was consid-
ered as missing. All the lengths of stay were computed
using exact days (number of hours/24) but for cases
missing any information on time, we calculated lengths
of stay according to the rule proposed by Ruttiman and
Pollack [33].
At the end of the study period, each study unit was
required to re-abstract the data of a maximum of three
cases identified by the CCC for quality control.
Statistical analysis
Quality control assessment was performed comparing
data of re-scored patients to their original counterparts
through kappa coefficients and intraclass correlation
coefficients, as appropriate.
Categorical variables are described as counts and per-
centages, and continuous variables as mean and stand-
ard deviation if normally distributed, or median with
interquartile (IQR) range. Comparisons between patients
in units with and without an IMCU in the hospital were
performed using chi-squared or Fisher exact test, and
Student t test.
Regression analyses were conducted to assess the asso-
ciation between the availability of IMCU and hospital
mortality. As the availability of an IMCU is a centre-level
factor, generalized estimating equation (GEE) models were
used to account for the correlation of patients within
centres [34]. GEE produces estimates comparable to
those from ordinary logistic regression but adjusts the
confidence interval for the correlation of outcomes
within-centre.
Univariate odds ratios (ORs) were reported with 95%
confidence intervals (CI). The log-linearity of the SAPS II
parameter was checked. A multivariable analysis was con-
ducted to adjust for the potential confounders selected
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patient level factors related to health status at admis-
sion (‘basic observation’ as reason for ICU admission,
SAPS II, infection, planned/unplanned admission to the
ICU, number of days in hospital before ICU admission
and intra-hospital location before ICU admission), cha-
racteristics of units or hospitals (number of hospital beds,
adjusted number of ICU beds) and countries. The orga-
nization of ICU was captured by the following factors:
possibility of allocating extra beds inside the ICU, having
intermediate care beds inside the ICU and ICU nurse to
patient ratio during daytime hours. A model with an inter-
action term was also performed to test the modification of
the effect of presence of an IMCU according to the reason
of admission (‘basic observation’ versus reasons requiring
intensive treatment).
Ethical approval
Ethics requirements differed by country. Given the de-
sign of ELOISE study, and given the regulations in
Austria, Poland and Switzerland no ethics approval was
required. In France, the ‘Groupe Ethique de l’associa-
tion pour la Formation et la Recherché en anesthésie-
réanimation’ approved the study. In the UK, the National
Research Ethics Committee London - Harrow approved
the study. In some countries (Belgium, Denmark, and
Norway), the ethical approval obtained by the coordinat-
ing centre was valid for all the centres in the same coun-
try. In some countries (Ireland, Italy), ethics requirements
differed by centres of the same country. Moreover, in
some centres, the study was considered and managed as
an audit. However, each unit was responsible for obtain-
ing local permissions, as necessary, according to local
regulations.
The following ethical bodies approved the study: Com-
missie voor Medische Ethiek - Ghent University Hospital;
Comité d’éthique des Cliniques de l’Europe; Comité d’ethi-
que Hospitalo-Facultaire Universitaire de Liège; Ethisch
Comité Onze Lieve Vrouwziekenhuis Aalst; Ethics Com-
mittee of the Teaching Hospital and Medical Faculty Plzen;
Etická komise FN Brno; Ethics Committee of the Univer-
sity Hospital in Hradec Kralove; Regional Scientific Ethics
Committee of Southern Denmark; Ethics Committee of
the University of Leipzig, Germany; Ethik-Kommission der
Medizinischen Fakultät der Ruhr Universität Bochum,
Germany; Scientific Committee of Attikon University Hos-
pital; Scientific Board of G. Gennimatas General Hospital,
Thessaloniki; Scientific Board of AHEPA University Gen-
eral Hospital of Thessaloniki; Scientific Committee of
Aretaieion University Hospital, Athens; Ethics Com-
mittee of the University Hospital of Larissa; University
Hospital of Ioannina Ethics Committee; Scientific Council
of Hippokration General Hospital of Thessaloniki; Sotiria
Hospital Ethics Committee, Athens; Ethics Committee ofPapanikolaou Hospital, Thessaloniki; Scientific Committee
of ‘Agioi Anargyroi’ Hospital, Athens; Naval Hospital of
Athens Ethics Committee; Scientific Board of Sismanoglio
General Hospital; Scientific Committee of IASO Center
Thessalias; Scientific Committee of Artas General Hos-
pital; Clinical Research Ethics Committee of the Cork
Teaching Hospitals; Ethics (Medical Research) Committee,
Beaumont Hospital, Dublin; Ethics and Medical Research
Committee, St Vincent’s Healthcare Group Ltd.; Comitato
Etico Indipendente dell’Azienda Ospedaliero-Universitaria
di Bologna; Comitato Etico della Provincia di Ferrara;
Comitato Etico Interaziendale AUSL Bologna e Imola;
Comitato bioetico dell’ARNAS Ospedale Civico Di Cristina
Benfratelli di Palermo; Modena Local Ethics Committee;
Comitato Etico Azienda Ospedaliera San Paolo, Milano;
Medical and Health Research Ethics Committee of
REK Sør-Øst. Centre: Stavanger University Hospital; REK
Sør-Øst. Centre: Ålesund Hospital; Comissão de Ética
para a Saúde do CHLC; Comissão de Ética para a Saúde
do Centro Hospitalar de Coimbra; Unidade Local de
Saúde de Matosinhos Ethics Committee; Comissão de
Ética da Unidade Local de Saúde do Alto Minho;
Comissão de Ética para a Saúde do Hospital S. João;
Comissão de Ética para a Saúde do Centro Hospitalar
de Setúbal; Ethics Committee of Emergency County
Hospital Cluj-Napoca; Ethics Committee of Emergency
Institute of Cardiovascular Diseases ‘Prof. Dr. C. C. Iliescu’,
Bucharest, Romania; University Emergency County
Hospital Mures Local Ethics Committee; Comisia Locala
de Etica - Spitalul Universitar de Urgenta Elias; Ethics
Committee of Emergency Institute of Cardiovascular Dis-
eases “Prof. Dr. C. C. Iliescu”, Bucharest, Romania; Clinical
Emergency Hospital of Bucharest Local Ethics Committee;
Ethics Committee of Clinical Emergency County Hospital
Timisoara; Education and Medical Research Committee
of Spitalul Judetean de Urgenta ‘Dr. Constantin Opris’
Baia Mare; Consiliul Etical Institutul Clinic Fundeni Cen-
ter; Comité Ético de Investigación Clínica de Cartagena;
Investigation Committee of Hospital Universitario de
Torrejón; Comité de Etica de Investigación Clínica de la
Universidad de Navarra; Istanbul University Cerrahpasa
Medical School, Clinical Research Ethics Committee;
Ethics Committee of the Ankara Numune Training and
Research Hospital; Clinical Research Ethics Committee of
Tepecik Training and Research Hospital; Mersin Univer-
sity Clinical Research Ethics Committee; Bakırköy Dr. Sadi
Konuk Education and Research Hospital.
Results
We collected data for 6,401 admissions to 169 partici-
pating units in 17 European countries. Data quality con-
trol was performed on 281 (4%) records. The median
number of missing data was 0.29 (IQR 0.11 to 0.62) per
unit. Data quality was excellent (Additional file 1), as
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to higher LOC before ICU’ and ‘Readmission’ had bor-
derline kappa values (0.842 and 0.838, respectively).
Of the participating units, 167 (98.8%) qualified them-
selves as being able to provide LOC III, which is to care
for patients with multiple acute vital organ failure who
cannot be accommodated in other units. The remaining
two units (from Austria and France) qualified themselves
as only able to provide LOC I and II, respectively. To
make the study sample as homogeneous as possible, the
subsequent analysis was done on the data collected from
the 167 units providing LOC III as the highest LOC, and
they will be named ICUs hereafter.
Most of the ICUs (140 of 167, 84%) were in a hos-
pital with at least one independent IMCU. This pro-
portion ranged from 70% (Greece) to 100% (Portugal)
in the countries represented by more than eight ICUs
(Additional file 2). Only 31 of these ICUs (22.1%)
were in hospitals with only one IMCU. The median num-
ber of IMCUs present in the hospitals was three (IQR 2 to
4.25). The most represented specialities of IMCUs were
cardiology (present in 93), surgery (62) including general
and speciality, internal medicine (38), neurology (38), and
emergency (17), while 23 IMCU were mixed. The median
number of IMCU beds in the hospital was 12 (IQR 4 toFigure 1 Flowchart of the patients included in the study.20) for an IMCU providing LOC II (monitoring and
pharmacological and/or device-related support of only
one acutely failing vital organ system) and 10 (IQR 4 to
24) for those providing LOC I (monitoring and minor
pharmacological or device-related support).
The number of acute hospital beds and the number of
ICU staffed beds, both absolute and adjusted, were sig-
nificantly higher in ICUs with an IMCU in the hospital
than in those without it (organisational characteristics of
study ICUs in Additional file 3). Fifty-one of the ICUs in
hospitals with an IMCU (36.4%) and seven (25.9%) of
the ICUs in hospitals without an IMCU had some inter-
mediate care beds inside the ICU.
There were 6,401 admissions collected by the study
ICUs (Figure 1), 2,625 collected by 64 ICUs in the first,
and 3,776 by 103 ICUs in the second slot period. The
median number of admissions collected by each ICU
was 32 (IQR 20 to 53). The exclusion of re-admissions
during the same hospital course (337), of cases with ICU
admission date out of the slots (49), or inconsistencies in
discharge data (34), or unknown vital status at hospital
discharge (82 still in hospital at 90-day follow-up, and 65
missing) left 5,834 patients for the analysis. Of the 5,834
patients studied, 1,397 (23.9%) died in hospital of which
1,113 (19.1%) died in ICU. The numbers of patients
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pital were 5,031 (86.2%) and 803 (13.8%), respectively.
The patient and hospital characteristics according to
the admission to ICU with or without an IMCU in the
hospital are described in Table 1 and the reasons for
ICU admission are reported in Additional file 4. The illness
severity (especially SAPS II) was higher and ICU admis-
sions were more frequently unplanned for patients in ICUs
with an IMCU than for patients in ICUs without an IMCU.
In agreement with the observed severity of illness of
patients, crude hospital mortality was higher in ICUs with
an IMCU (1232/5031, 24.5%) than in ICUs without an
IMCU (165/803, 20.5%, P = 0.017). The IMCU was the
discharge location for 721 (18.8%) of the 4,049 survivors of
ICUs with an IMCU in the hospital while 44 (6.7%) of the
572 survivors of ICUs without an IMCU were discharged
to an IMCU of another hospital. Information about thera-
peutic limitations was missing in 336 cases. In the 5,498
patients (94.2%) having information, recorded therapeutic
limitations were applied during ICU stay and/or planned at
ICU discharge in 601 (12.6%) and 87 (11.6%) patients
admitted respectively to ICUs with and without an IMCU.
Main characteristics of patients with and without any
therapeutic limitation are reported in Figure 2. The SOFA
score at ICU discharge was not significantly different in
patients discharged from ICUs with and without an IMCU
in the hospital (median (IQR): 1 (0 to 3) versus 1 (0 to 2),
P = 0.361). NEMS at admission was higher in patients in
ICUs with an IMCU (median (IQR): 29 (23 to 38) versus
27 (18 to 34), P <0.001) whereas NEMS at ICU discharge
was similar (median (IQR) 18 (15 to 20) versus 18
(15 to 18), P = 0.89). Furthermore, the length of stay
in an ICU with an IMCU was longer than in ICU
without an IMCU (median (IQR) 3.5 (1.9 to 6.9) versus
2.6 (1.8 to 4.3), P <0.001). These findings suggest that the
discharge policy is not different between the ICUs with an
IMCU and ICUs without an IMCU, the patients are
discharged at equivalent NEMS.
There were 292 readmissions to ICUs with an IMCU
and 40 readmissions to ICUs without an IMCU; five
readmissions were excluded due to data inconsistencies.
After the exclusion of readmissions with unknown hos-
pital outcome, the hospital mortality after readmission
was 37.7% (N = 103) and 27.0% (N = 10) in ICUs with
and without an IMCU, respectively.
The variables entered into the multivariable analysis
are reported in Table 2. The fully adjusted multivariable
logistic regression analysis showed an OR of 0.63 (95%
CI 0.45 to 0.88, P = 0.007) in favour of the presence of
an IMCU. We performed a sensitivity analysis to check
the robustness of this finding using SAPS 3, the SOFA
and the NEMS scores instead of the SAPS II as acuity
adjustor, by replacing SAPS II with each of these scores
in the multivariate model. The OR with adjustment basedon SAPS 3 was 0.66 (95% CI 0.46 to 0.94), 0.59 (95% CI
0.41 to 0.84) with adjustment based on SOFA, 0.55
(95% CI 0.39 to 0.78) with adjustment on NEMS. Severity
of illness at ICU admission, presence of infection, hospital
stay longer than seven days before ICU admission, and
unplanned admission to the ICU were the patients’ factors
significantly associated with an increased risk of hospital
death, while ‘basic observation’ as the reason for ICU ad-
mission was a protective factor. Moreover, considering
that Coronary Care Units are different from other IMCUs,
we performed the multivariable analysis excluding the
study patients admitted to the ICUs having a Coronary
Care Unit as the only IMCU in the hospital. Only 31
(22.1%) of the 140 ICUs in a hospital with at least one
independent IMCU had only one IMCU, and 12 of them
were cardiac. The OR was 0.66 (95% CI 0.47 to 0.92,
P = 0.015) in favour of the presence of an IMCU.
In a further sensitivity model, with an interaction term
between presence of an IMCU and the reason for admis-
sion (‘basic observation’ versus other), the adjusted OR
for the patients admitted to ICU for ‘basic observation’
was 1.15 (95% CI 0.65 to 2.03, P = 0.630) and that for
patients requiring intensive treatment was 0.54 (95% CI
0.37 to 0.80, P = 0.002). The difference between these
two ORs was statistically significant (P = 0.025). This
suggests a possible interaction between the severity of
illness of the patients with the effects of the presence or
absence of an independent IMCU.
Discussion
This prospective multinational European study is the
first which demonstrates that adults admitted to ICUs of
hospitals with an IMCU have significantly lower adjusted
hospital mortality than those admitted to ICUs of hospi-
tals without an IMCU. The adjusted IMCU effect in our
study was close to one in the patients admitted to ICU
for ‘basic observation’, and significantly lower than one
(OR 0.54, 95% CI 0.37 to 0.80) for the patients admitted
for other reasons, that is for those needing intensive
treatment. Therefore, the finding of improved mortality
associated with presence of an IMCU concerns the
patients needing the intensive treatments performed in
ICU.
We investigated only the effect of the presence of
physically and administratively independent IMCUs on
hospital mortality of ICU patients because intermediate
care beds inside the ICU represent in many cases a
management to match the level of care provided to ICU
patients daily with the staff resources [35].
The large number of units and admissions collected is
one of the major strengths of the present study. The
quality of data collected is excellent as shown by the low
number of missing data and patient exclusions, mostly
due to being still in hospital at 90 days. The adjustment
Table 1 Patient and hospital characteristics according to the absence or presence of an Intermediate Care Unit in the
hospital
Patients admitted to ICU With IMCU Without IMCU P value
Number 5031 803
Gender Female 2002 (39.8%) 332 (41.3%) 0.427
Male 3029 (60.2%) 471 (58.7%)
Age, years Median (IQR) 65 (52-75) 68 (55-77) <0.001
Missing 14 2
Transfer to higher LOC before ICU admission No 4464 (88.9%) 785 (97.8%) <0.001
Yes 558 (11.1%) 18 (2.2%)a
Missing 9 0
Intra-hospital location before ICU admission Emergency room 1828 (36.7%) 218 (27.2%) <0.001
Intermediate care 338 (6.8%) 33 (4.1%)a
Other ICU 243 (4.9%) 27 (3.4%)
Ward, other 2571 (51.6%) 523 (65.3%)
Missing 51 2
ICU admission Planned 1471 (29.3%) 331 (41.2%) <0.001
Unplanned 3554 (70.7%) 472 (58.8%)
Missing 6 0
‘Basic observation’ as ICU admission reason No 3804 (75.6%) 475 (59.2%) <0.001
Yes 1227 (24.4%) 328 (40.8%)
Surgery Emergency surgery 993 (19.8%) 128 (15.9%) <0.001
No surgery 2603 (51.8%) 361 (45%)
Scheduled surgery 1426 (28.4%) 314 (39.1%)
Missing 9 0
Infection at ICU admission No 3461 (69.9%) 652 (81.5%) <0.001
Yes 1492 (30.1%) 148 (18.5%)
Missing 78 3
SAPS II Median (IQR) 37 (24-53) 29 (20-45) <0.001
SAPS II predicted mortality Median (IQR) 0.20 (0.06-0.53) 0.10 (0.04-0.35) <0.001
Missing 59 3
SAPS 3 Median (IQR) 35 (23-48) 28 (19-41) <0.001
SAPS 3 predicted mortality Median (IQR) 0.19 (0.06-0.44) 0.10 (0.04-0.30) <0.001
Missing 55 7
ICU length of stay, days Median (IQR) 3.7 (1.9-7.7) 2.8 (1.8-4.8) <0.001
Missing 48 5
ICU outcome Survival 4049 (80.5%) 672 (83.7%) 0.036
Death 982 (19.5%) 131 (16.3%)
Hospital length of stay, days Median (IQR) 13.9 (7.6-25) 11.0 (6.2-19) <0.001
Missing 71 10
Hospital outcome Survival 3799 (75.5%) 638 (79.5%) 0.017
Death 1232 (24.5%) 165 (20.5%)
Hospital characteristics
Number of hospital beds category <500 1123 (23.3%) 507 (63.8%) <0.001
500-1000 2519 (52.2%) 288 (36.2%)
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Table 1 Patient and hospital characteristics according to the absence or presence of an Intermediate Care Unit in the
hospital (Continued)
>1000 1180 (24.5%) 0 (0%)
Missing 209 8
ICU adjusted beds categoryb <8 406 (8.1%) 307 (38.2%) <0.001
8-12 1879 (37.3%) 358 (44.6%)
>12 2746 (54.6%) 138 (17.2%)
Teaching status of the hospital Non-teaching 495 (9.8%) 306 (38.1%) <0.001
Teaching 4536 (90.2%) 497 (61.9%)
Profit status of the hospital For-profit 28 (0.6%) 84 (10.5%) <0.001
Non-profit 5003 (99.4%) 719 (89.5%)
Possibility of extra beds inside ICU No 3921 (77.9%) 696 (86.7%) <0.001
Yes 1110 (22.1%) 107 (13.3%)
ICU nurse: patient ratio in daytimec <0.5 1255 (24.9%) 0 (0%) <0.001
0.5-1 2382 (47.3%) 466 (58%)
>1 1394 (27.7%) 337 (42%)
aIMCUs of any other hospital different from that of the ICU; bnumber of ICU staffed beds adjusted for the ICUs having intermediate care beds inside considering
two intermediate care beds inside ICU to be equivalent to one ICU bed; ccomputed for only registered nurses. Data are number (N) with percentage or median
with interquartile range (IQR). ICU: Intensive Care Unit; IMCU: Intermediate Care Unit (physically and administratively independent unit present in the hospital);
LOC: Level of Care; SAPS: Simplified Acute Physiology Score.
Patients admitted to ICUs without IMCU
TL: Therapeutic Limitation, including withholding and withdrawing, applied and/or planned during ICU stay; LOS: Length of stay 
Adm.: admission; Disch: discharge; HO: hospital; * patients discharged to IMCU of other hospitals
Surviving ICU: 667Dead in ICU: 81
With TL  28 (34.6%)
Age 66 (61 - 76) 
Unplanned adm. 23 (82%)
Medical 21 (75%)
SAPS II67.5 (49.75 - 90.75) 
ICU LOS 3.3 (1.9 - 8.3) 
Without TL 53 (65.4%) 
Age 70 (61 - 78) 
Unplanned adm. 50 (94%)
Medical 37 (70%)
SAPS II 67 (44 - 80) 
ICU LOS 3.4 (1.8 - 7.4) 
With TL 59 (8.8%)
Age 70 (56 - 78) 
Unplanned adm. 32 (54%)
Medical 26 (44%
SAPS II 31 (23 - 43.5) 
ICU LOS 2.6 (1.8 - 11.4) 
Discharge SOFA 1 (0 - 3) 
Disch. to IMCU 0
Dead in HO 11 (19%)
Without TL 608 (91.2%)
Age 66 (54 - 76) 
Unplanned adm. 320 (53%)
Medical 238 (39%)
SAPS II 26 (18 – 36) 
ICU LOS 2.5 (1.8 - 4.1) 
Discharge SOFA 1 (0 - 2) 
Disch. to IMCU* 44 (7%)
Dead in HO 22 (4%)
Patients admitted to ICUs with IMCU
Surviving ICU: 3989Dead in ICU: 761
With TL 352 (46.2%)
Age 71 (60 - 79.25) 
Unplanned adm. 325 (93%)
Medical 266 (76%)
SAPS II 63.5 (50 - 78) 
ICU LOS 4.8 (2.1 - 10.9) 
Without TL 409 (53.8%)
Age 69 (58 - 78) 
Unplanned adm. 363 (89%)
Medical 287 (70%)
SAPS II 62.5 (49 - 79) 
ICU LOS 4.5 (1.7 - 9.9) 
Without TL 3740 (96.8%)
Age 63 (50 - 73) 
Unplanned adm. 2434 (65%)
Medical 1690 (45%)
SAPS II 32 (22 - 44) 
ICU LOS 3.3 (1.9 - 6.7) 
Discharge SOFA 1 (0 - 3) 
Disch. to IMCU 678 (19%)
Dead in HO 180 (5%)
With TL 249 (6.2%)
Age 71 (59 - 80) 
Unplanned adm. 206 (83%)
Medical 171 (69%)
SAPS II 47 (37 - 58) 
ICU LOS 5.7 (2.8 - 10.9) 
Discharge SOFA 2 (1 - 4) 
Disch. to IMCU 40 (17%)
Dead in HO 66 (27%)
Figure 2 Therapeutic limitation, including withholding and withdrawing, applied and/or planned during intensive care unit (ICU) stay.
Data on 4,750 (94.4%) patients admitted to ICUs with an Intermediate Care Unit (IMCU) and 748 (93.1%) patients admitted to ICUs without IMCU.
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Table 2 Multivariable model for the association with
hospital mortality
Variable OR LL UL P value
IMCU in the hospital No 1
Yes 0.63 0.45 0.88 0.007
‘Basic observation’ as
ICU admission reasona
No 1
Yes 0.60 0.44 0.81 0.001
SAPS II Per unit 1.07 1.06 1.08 <0.001
Gender Female 1
Male 1.14 0.97 1.33 0.110
Infection No 1
Yes 1.38 1.17 1.62 <0.001
Intra-hospital location
before ICU admission
Emergency room 1
IMCU 1.09 0.76 1.56 0.635
Other ICU 1.24 0.83 1.85 0.295
Ward, other 1.16 0.93 1.45 0.200
Days in hospital before
ICU admission
<24 h 1
1-7 days 1.13 0.92 1.40 0.249
>7 days 1.79 1.35 2.36 <0.001
Adjusted number of
ICU bedsb
< 8 1
8-12 1.45 0.89 2.36 0.133
>12 1.20 0.71 2.04 0.497
Type of admission
to the ICU
Planned 1
Unplanned 1.42 1.11 1.83 0.006
Number of
hospital beds
<500 1
500-1,000 2.29 1.61 3.25 <0.001
>1,000 1.59 1.09 2.30 0.015
Possibility of allocating
extra beds inside the ICU
No 1
Yes 0.98 0.70 1.37 0.905
ICU nurse: patient
ratio in daytime
<0.5 1
0.5-1 1.16 0.79 1.71 0.449
>1 1.30 0.80 2.10 0.285
Having intermediate
care beds inside the ICU
No 1
Yes 0.99 0.73 1.35 0.968
a‘Basic observation’ generated according to the SOFA and NEMS variables for
missing cases; bnumber of ICU staffed beds adjusted for the ICUs having
intermediate care beds inside considering two intermediate care beds inside ICU
to be equivalent to one ICU bed. The presented odds ratios are adjusted on
countries. OR: odds ratio, 95% confidence intervals reported as lower limit (LL)
and upper limit (UL); LOC: Level of Care; P value: statistical significance. ICU:
Intensive Care Unit; IMCU: Intermediate Care Unit: SAPS: Simplified Acute
Physiology Score; SOFA: Sequential Organ Failure Assessment; NEMS: nursing
workload index.
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moved the crude effect of a higher mortality for ICUs with
an IMCU in an opposite direction. In non-randomised
studies the case-mix adjustment is problematical but
necessary [36]. In our study the adjustment was based
on patient factors - including SAPS II, admission for
‘basic observation’, presence of infection, more than seven
days in hospital before ICU admission and unplanned
ICU admission. Besides the patients’ characteristics, we
adjusted for countries because we suspected that mortality
and health care management vary across countries. Add-
itionally, some ICU and hospital characteristics have been
introduced in the multivariate model to capture the hos-
pital/ICU size (adjusted number of ICU beds, number of
hospital beds). The organization of ICU was captured by
the following factors: possibility of allocating extra beds
inside the ICU, having intermediate care beds inside the
ICU and ICU nurse to patient ratio during daytime hours.
The size of the hospitals with and without an IMCU is
different, being the former larger than the latter (median
number of beds 665 vs. 294). A relationship between high
volume and better outcome was reported in the EURICUS
I database [37], for some high-risk surgical patients [38]
and ICU cancer patients with septic shock [39], and a
systematic review [40] confirmed this finding. Neverthe-
less, the volume-outcome relationship has been ques-
tioned [41] and a recent study found no correlation
between standardized mortality ratio and ICU volume
with only mechanically ventilated patients in very
low-volume centres [42]. However, in our study we ad-
justed hospital mortality also for the size of the hospitals,
which was strongly related to the volume of activity.
Therefore, we have reason to believe that our finding is
not due to the volume-outcome relationship.
Other relevant issues we had to deal with are the re-
cently reported marked heterogeneity between European
countries in the numbers of critical care beds [43], and
the high number of ICUs from Central and Mediterranean
countries present in our study. Fifteen of the seventeen
countries participating in our study participated also in
the European Surgical Outcomes Study (EuSOS) [44],
which was designed to assess outcomes after non-cardiac
surgery in Europe and collected data on 46,539 patients,
36,769 (79%) of which in the same countries as the
present study. The weight of the geographic areas is dif-
ferent in EuSOS and in the present study, with Central
and Western Europe prevalent in EuSOS, and Southern
Europe and Mediterranean Countries prevalent in our
study. When compared with the UK, the mortality rates
recorded in EuSOS for three countries included also in
the present study (Poland, Romania, and Ireland) are
higher even after adjustment for the confounding variables
identified in that study. Both this result [45-48] and the
methodology [49,50] of EuSOS have been questioned,
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excluding 72 centres and 944 patients from the cohort
remained consistent with the original conclusion that
mortality was higher than expected, with significant varia-
tions between nations [51]. The methodology of our study
is very different to EuSOS. However, we have taken into
account the variations between countries and adjusted the
IMCU effect on hospital mortality on countries.
In ICUs with an IMCU in the hospital, few patients
(6.8%) were admitted from IMCU and less than one fifth
of the survivors (18.8%) were transferred from ICU to
IMCU. This percentage is not too different from that
reported by Ranzani et al. who discharged 23% of
their patients to IMCU [52]. Of note, the exclusion of the
patients admitted to the 12 ICUs having a Coronary Care
Unit as the only IMCU in the hospital did not change our
results on hospital mortality. This finding may suggest
that IMCUs, either cardiac or not, have an effect on
hospital mortality of ICU patients, possibly because
ICU-discharged patients having a late cardiac complica-
tion may benefit from these units.
There are several hypotheses that may explain how
independent IMCUs can affect ICU patient outcome.
First, the patients admitted to ICUs without an IMCU in
the hospital could be less seriously ill than those admit-
ted to ICUs with an IMCU as physicians may prefer an
early, safer, transfer to ICU. Second, the patients admit-
ted to ICUs without an IMCU in the hospital could be
more seriously ill than those admitted to ICUs with an
IMCU due to suboptimal care on ward, or deterioration
not recognised in time. The first or the second hypoth-
esis may prevail depending on the pressure on ICU beds.
Our findings show that patients admitted to ICUs with-
out an IMCU were less seriously ill than those admitted
to ICUs with an IMCU in agreement with the first hy-
pothesis. But the IMCU effect detected in the regression
model cannot be explained by the severity of illness at
admission as the model was adjusted for this confounding
variable. Third, the patients admitted to ICUs without an
IMCU in the hospital could have a longer ICU stay than
those admitted to ICUs with an IMCU, needing more
time to reach the level of nursing workload given in the
ward. Fourth, the patients admitted to ICUs without an
IMCU could be discharged from ICU too early, with a
higher SOFA score and nursing workload, than those
discharged from ICUs with an IMCU. In our study, the
patient length of stay in ICUs without an IMCU was
shorter than in ICUs with an IMCU. The SOFA and the
NEMS scores at ICU discharge were similar in patients
discharged from ICUs with and without an IMCU, sug-
gesting the third and fourth hypotheses are wrong. We
cannot exclude that things may be different at times of
pressure on ICU beds but we do not have information
about bed pressure.The mechanisms explaining the lower in-hospital mor-
tality in centres with an IMCU could be related to mul-
tiple different reasons. The monitoring and treatment
provided by an IMCU to the patients needing it before
ICU admission, and especially after ICU discharge, could
have played a role, but cannot alone explain the main
finding of the study. Possibly, the presence of an IMCU
treating patients not admitted to ICU, especially in times
of pressure on ICU beds, may have avoided an increase
of the ICU staffing workload connected to the patient
turnover (admissions, transfers and discharges). ICU
staffing workload has been demonstrated to be associated
with increased mortality [53], and West et al. [54] recently
found a relationship between high staffing workload -
measured by occupancy, admissions and transfers - and
increased ICU mortality on 38,168 patients admitted to 65
UK ICUs collected in 1998. Therefore, we can hypothesise
that an IMCU may have affected the in-hospital mortality
of ICU patients also by a mechanism of reduction of ICU
staffing workload. Unfortunately, our study did not assess
the staffing workload of ICUs with and without IMCUs,
and the functions of IMCUs where present, that is
whether they facilitated earlier discharges of the ICU pa-
tients or ensured timely care for the patients deteriorating
on the wards, or both.
The present study has some limitations. It is obser-
vational, because the decision to introduce an IMCU in
hospitals or to assign patients to ICUs was outside the
control of the investigators. It was performed only in ICUs
participating on a voluntary basis, with some countries
poorly represented, and hence participating ICUs did not
necessarily represent the case mix of that country and our
finding may not apply to all geographic locations. The
selection of ICUs was not done randomly and can suffer
from the effect of selection bias by the country coordina-
tors. Moreover, the strict respect for patient anonymity
did not give us solid clues to match each readmission with
its first ICU admission. The effect of an IMCU was ana-
lysed only by the perspective of intensive care, thus noth-
ing can be said about the possible effects of the presence,
or absence, of IMCU on the outcome of patients hospital-
ized in other units. The small sample size and number of
events in some participating centres is a limitation in our
analysis because we modelled the mortality using methods
for clustered data with centres as clusters. Nevertheless,
our purpose was to assess the association between the
presence of an IMCU and mortality, globally and not by
centre, and the statistical power was sufficient since this
association was statistically significant. Moreover, we can-
not exclude that some confounding factors have been
omitted in our model. Unfortunately, we did not assess
characteristics and development of the teamwork in ICU,
and whether the ICU and IMCU of the hospital shared
the same staff. Teamwork is important to improve patient
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should be prepared to join them for epidemics or mass
casualties [56]. We could hypothesise a better patient
outcome when the ICU and IMCU share the same
staff compared to ICUs without an IMCU or with a totally
independent IMCU, but we do not have data. Finally, we
did not collect information about the daily ICU occupancy
rate, or other measure of staffing workload which could
indicate the ICU/IMCU relationship.
Conclusions
This study is the first to provide evidence of the positive
effect of having any physically and administratively inde-
pendent intermediate care unit in the hospital on the
mortality of adults admitted to ICU. This finding is rele-
vant to health system and hospital managers who can
find a scientific support to the decision to invest in having
intermediate care beds in the hospital. Our study does not
give evidence about the best staff to be involved in the
management of intermediate care beds to improve patient
outcome. Moreover, the differences in hospital and ICU
beds, and characteristics of ICU-admitted patients found
in the present study testify that settings with and without
an IMCU may be basically different, and hence economic
aspects may play a role in the decision of having inter-
mediate care or not.
One of the main challenges now is to quantify and
to compare the effects on patient outcomes and costs
between two models: an independent IMCU operating
in collaboration with ICUs and intermediate care beds in-
side large ICUs completely dependent from the ICU staff.
Key messages
 IMCUs, which treat patients who require more care
than could be provided on wards, may improve the
outcome of ICU patients.
 We analyzed data collected on 5,834 patients
admitted to 167 ICUs from 17 European countries.
 Patients admitted to ICUs with an IMCU in the
hospital had a significantly reduced mortality, in
comparison with patients admitted to ICUs
without an IMCU in the hospital.
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